Maria L Mittal1,2, Andrew Guise1,3, Claudia Rafful1,4, Patricia Gonzalez-Zuñiga1, Peter Davidson1, Devesh Vashishtha1, Steffanie A Strathdee1, Dan Werb1,4. 1. Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA. 2. Facultad de Medicina, Universidad Xochicalco, Tijuana, Mexico. 3. Division of Health and Social Care Research, King's College, London, UK. 4. Centre on Drug Policy Evaluation, St. Michael's Hospital, Toronto, ON, Canada.
Abstract
Background: Persons who inject drugs (PWID) play a key role in assisting others' initiation into injection drug use (IDU). We aimed to explore the pathways and socio-structural contexts for this phenomenon in Tijuana, Mexico, a border setting marked by a large PWID population with limited access to health and social services. Methods: Preventing Injecting by Modifying Existing Responses (PRIMER) is a multi-cohort study assessing socio-structural factors associated with PWID assisting others into initiating IDU. Semi-structured qualitative interviews in Tijuana included participants ≥18 years old, who reported IDU within the month prior to cohort enrollment and ever initiating others into IDU. Purposive sampling ensured a range of drug use experiences and behaviors related to injection initiation assistance. Thematic analysis was used to develop recurring and significant data categories. Results: Twenty-one participants were interviewed (8 women, 13 men). Broadly, participants considered public injection to increase curiosity about IDU. Many considered transitioning into IDU as inevitable. Emergent themes included providing assistance to mitigate overdose risk and to protect initiates from being taken advantage of by others. Participants described reluctance in engaging in this process. For some, access to resources (e.g., shared drugs or a monetary fee) was a motivator to initiate others. Conclusion: In Tijuana, public injection and a lack of harm reduction services are perceived to fuel the incidence of IDU initiation and to incentivize PWID to assist in injection initiation. IDU prevention efforts should address structural factors driving PWID participation in IDU initiation while including PWID in their development and implementation.
Background: Persons who inject drugs (PWID) play a key role in assisting others' initiation into injection drug use (IDU). We aimed to explore the pathways and socio-structural contexts for this phenomenon in Tijuana, Mexico, a border setting marked by a large PWID population with limited access to health and social services. Methods: Preventing Injecting by Modifying Existing Responses (PRIMER) is a multi-cohort study assessing socio-structural factors associated with PWID assisting others into initiating IDU. Semi-structured qualitative interviews in Tijuana included participants ≥18 years old, who reported IDU within the month prior to cohort enrollment and ever initiating others into IDU. Purposive sampling ensured a range of drug use experiences and behaviors related to injection initiation assistance. Thematic analysis was used to develop recurring and significant data categories. Results: Twenty-one participants were interviewed (8 women, 13 men). Broadly, participants considered public injection to increase curiosity about IDU. Many considered transitioning into IDU as inevitable. Emergent themes included providing assistance to mitigate overdose risk and to protect initiates from being taken advantage of by others. Participants described reluctance in engaging in this process. For some, access to resources (e.g., shared drugs or a monetary fee) was a motivator to initiate others. Conclusion: In Tijuana, public injection and a lack of harm reduction services are perceived to fuel the incidence of IDU initiation and to incentivize PWID to assist in injection initiation. IDU prevention efforts should address structural factors driving PWID participation in IDU initiation while including PWID in their development and implementation.
Entities:
Keywords:
HCV prevention; HIV prevention; Mexico; North America; injection initiation assistance
Authors: Evan Wood; Mark W Tyndall; Ruth Zhang; Jo-Anne Stoltz; Calvin Lai; Julio S G Montaner; Thomas Kerr Journal: N Engl J Med Date: 2006-06-08 Impact factor: 91.245
Authors: Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt Journal: Lancet Date: 2011-07-27 Impact factor: 79.321
Authors: Leo Beletsky; Pieter Baker; Jaime Arredondo; Ashley Emuka; David Goodman-Meza; Maria Elena Medina-Mora; Dan Werb; Peter Davidson; Joseph J Amon; Steffanie Strathdee; Carlos Magis-Rodriguez Journal: Lancet Date: 2018-08-16 Impact factor: 79.321
Authors: Emily F Wood; Dan Werb; Leo Beletsky; Gudelia Rangel; Jazmine Cuevas Mota; Richard S Garfein; Steffanie A Strathdee; Karla D Wagner Journal: Int J Drug Policy Date: 2017-01-19
Authors: Kelsey A Simpson; Alex H Kral; Jesse L Goldshear; Lynn Wenger; Carol S Strike; Ricky N Bluthenthal Journal: Drug Alcohol Depend Date: 2020-02-05 Impact factor: 4.492